K. Schatteman

548 total citations
15 papers, 353 citations indexed

About

K. Schatteman is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, K. Schatteman has authored 15 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in K. Schatteman's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Signaling Pathways in Disease (6 papers) and Peptidase Inhibition and Analysis (6 papers). K. Schatteman is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Signaling Pathways in Disease (6 papers) and Peptidase Inhibition and Analysis (6 papers). K. Schatteman collaborates with scholars based in Belgium, Brazil and Sweden. K. Schatteman's co-authors include Dirk Hendriks, Simon Scharpé, Filip Goossens, Judith Leurs, Hugo Neels, Viveca Nerme, J. Wauters, Paul Bossuyt, Greet Vanhoof and Petter Björquist and has published in prestigious journals such as Clinical Chemistry, Clinica Chimica Acta and Thrombosis and Haemostasis.

In The Last Decade

K. Schatteman

15 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Schatteman Belgium 11 211 106 76 74 67 15 353
Judith Leurs Belgium 11 274 1.3× 102 1.0× 42 0.6× 84 1.1× 103 1.5× 12 400
F Fernandez-Rachubinski Canada 11 140 0.7× 177 1.7× 57 0.8× 47 0.6× 47 0.7× 17 345
Bibian M. E. Tullemans Netherlands 13 156 0.7× 81 0.8× 43 0.6× 35 0.5× 75 1.1× 22 330
Isabell Seitz Germany 10 163 0.8× 257 2.4× 43 0.6× 103 1.4× 184 2.7× 11 554
I.M. Nilsson Sweden 11 119 0.6× 58 0.5× 93 1.2× 99 1.3× 23 0.3× 20 367
Behnoush Parviz Germany 10 91 0.4× 149 1.4× 31 0.4× 149 2.0× 59 0.9× 18 413
Beatriz Sánchez-Vega Spain 12 125 0.6× 78 0.7× 93 1.2× 16 0.2× 106 1.6× 18 421
Julio C. Reséndiz Finland 10 229 1.1× 69 0.7× 17 0.2× 17 0.2× 156 2.3× 14 396
M Kuliszkiewicz-Janus Poland 11 81 0.4× 146 1.4× 57 0.8× 75 1.0× 13 0.2× 41 344
C Praga Italy 9 91 0.4× 50 0.5× 112 1.5× 50 0.7× 50 0.7× 26 299

Countries citing papers authored by K. Schatteman

Since Specialization
Citations

This map shows the geographic impact of K. Schatteman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Schatteman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Schatteman more than expected).

Fields of papers citing papers by K. Schatteman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Schatteman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Schatteman. The network helps show where K. Schatteman may publish in the future.

Co-authorship network of co-authors of K. Schatteman

This figure shows the co-authorship network connecting the top 25 collaborators of K. Schatteman. A scholar is included among the top collaborators of K. Schatteman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Schatteman. K. Schatteman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
hee, Paul Van, Hugo Neels, Mireille De Doncker, et al.. (2004). Analysis of γ-hydroxybutyric acid, DL-lactic acid, glycolic acid, ethylene glycol and other glycols in body fluids by a direct injection gas chromatography-mass spectrometry assay for wide use. Clinical Chemistry and Laboratory Medicine (CCLM). 42(11). 26 indexed citations
2.
Leurs, Judith, et al.. (2003). Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma. Thrombosis and Haemostasis. 89(2). 264–271. 37 indexed citations
3.
Abrahamsson, Tommy, Viveca Nerme, K. Schatteman, et al.. (2002). Local proCPU (TAFI) Activation during Thrombolytic Treatment in a Dog Model of Coronary Artery Thrombosis can be Inhibited with a Direct, Small Molecule Thrombin Inhibitor (Melagatran). Thrombosis and Haemostasis. 87(4). 557–562. 23 indexed citations
4.
Schatteman, K., et al.. (2001). Fast Homogeneous Assay for Plasma Procarboxypeptidase U. Clinical Chemistry and Laboratory Medicine (CCLM). 39(9). 806–10. 13 indexed citations
5.
Schatteman, K., Filip Goossens, Judith Leurs, et al.. (2001). arboxypeptidase U at the Interface Between Coagulation and Fibrinolysis. Clinical and Applied Thrombosis/Hemostasis. 7(2). 93–101. 10 indexed citations
6.
Strömqvist, Mats, K. Schatteman, Judith Leurs, et al.. (2001). Immunological Assay for the Determination of Procarboxypeptidase U Antigen Levels in Human Plasma. Thrombosis and Haemostasis. 85(1). 12–17. 38 indexed citations
7.
Schatteman, K., Filip Goossens, Simon Scharpé, & Dirk Hendriks. (2000). Proteolytic activation of purified human procarboxypeptidase U. Clinica Chimica Acta. 292(1-2). 25–40. 45 indexed citations
8.
Schatteman, K., Filip Goossens, Simon Scharpé, Hugo Neels, & Dirk Hendriks. (1999). Assay of Procarboxypeptidase U, a Novel Determinant of the Fibrinolytic Cascade, in Human Plasma. Clinical Chemistry. 45(6). 807–813. 67 indexed citations
9.
Schatteman, K., Filip Goossens, Simon Scharpé, & Dirk Hendriks. (1999). Activation of Plasma Procarboxypeptidase U in Different Mammalian Species Points to a Conserved Pathway of Inhibition of Fibrinolysis. Thrombosis and Haemostasis. 82(12). 1718–1721. 22 indexed citations
10.
Vanhoof, Greet, Filip Goossens, María A. Juliano, et al.. (1997). Isolation and sequence analysis of a human cDNA clone (XPNPEPL) homologous to X-prolyl aminopeptidase (aminopeptidase P). Cytogenetic and Genome Research. 78(3-4). 275–280. 8 indexed citations
11.
Vanhoof, Greet, et al.. (1997). 145 Procarboxypeptidase u is expressed in human liver. Fibrinolysis & proteolysis. 11. 41–41. 7 indexed citations
12.
Vanhoof, Greet, Filip Goossens, María A. Juliano, et al.. (1997). Human Lymphocyte X-Prolyl Aminopeptidase (Aminopeptidase P)-Like Protein. Advances in experimental medicine and biology. 421. 25–29. 5 indexed citations
13.
Vanhoof, Greet, K. Schatteman, Filip Goossens, Simon Scharpé, & Dirk Hendriks. (1997). Procarboxypeptidase U is expressed in human liver. 11. 41. 5 indexed citations
14.
Wauters, J., K. Schatteman, Dirk Hendriks, et al.. (1996). The Gene for Human Carboxypeptidase U (CPU)— A Proposed Novel Regulator of Plasminogen Activation— Maps to 13q14.11. Genomics. 38(3). 454–455. 35 indexed citations
15.
Goossens, Filip, J. Wauters, Greet Vanhoof, et al.. (1996). Subregional mapping of the human lymphocyte prolyl oligopeptidase gene (PREP) to human chromosome 6q22. Cytogenetic and Genome Research. 74(1-2). 99–101. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026